The present invention relates to Myoviridae bacteriophage Edw-TAP-1 (accession No. KCTC 12740BP) isolated from nature, characterized by holding an ability to specifically kill Edwardsiella tarda and having the genome represented by SEQ ID NO: 1, and to a method for preventing and treating the infection with Edwardsiella tarda using a composition containing the same as an active ingredient.
展开▼
机译:本发明涉及从自然界分离的肌病毒科噬菌体Edw-TAP-1(保藏号:KCTC 12740BP),其特征在于,它具有特异性杀死塔氏爱德华氏菌的能力,并具有SEQ ID NO:1所代表的基因组,以及使用包含其作为活性成分的组合物预防和治疗迟发性爱德华氏菌的方法。
展开▼